Supira's technology features a novel low profile, high continuous flow design that aims to provide full hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic shock (CS) patients with a single device
October 23, 2023
Supira Medical's Next Generation Percutaneous Ventricular Assist Device (pVAD) System to be Highlighted in a Live Case and Multiple Sessions at TCT23
October 23, 2023 — Supira Medical, Inc., a Shifamed portfolio company, announced that the company's percutaneous…
Read More
The ALIGN-AR trial is a landmark prospective, single-arm investigation device exemption (IDE) study designed to assess the safety and efficacy of the Trilogy THV System
October 20, 2023
JenaValve Announces ALIGN-AR Pivotal Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2023
October 20, 2023 — JenaValve Technology, Inc., developer and manufacturer of the Trilogy Transcatheter Heart Valve (THV…
Read More
Published late-breaking clinical data presented at TCT 2023
October 20, 2023
Philips Showcases Latest Medical Innovations and Solutions for Patients with Cardiovascular Disease TCT23
October 20, 2023 —  Over the coming days, Philips will be presenting its latest solutions in cardiology and new late-…
Read More
Published late-breaking clinical data presented at TCT 2023
October 20, 2023
Gene Discoveries Could Help Prevent Deadly Coronary Artery Disease
October 20, 2023 — An international team of scientists has identified nearly a dozen genes that contribute to calcium…
Read More
Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Oct. 24, 25 and 26
By Melinda Taschetta-Millane
October 20, 2023
TCT23 Late-breakers: Full Schedule Announced
Innovation. Connection. Inspiration. The Transcatheter Cardiovascular Therapeutics (TCT) 2023 conference, the  …
Read More
Novel platform for structural heart interventions now in human use, with ability to improve patient recovery and reduce anesthesia and hospital stays
October 19, 2023
UltraNav System Enables Safer and More Cost-Effective Transseptal Procedures by Aligning Catheter and Ultrasound
October 19, 2023 — The Dib UltraNav Transseptal Catheter System, which houses a needle and ultrasound in one system for…
Read More
The CLAAS System to be highlighted daily at TCT, including a live case presentation by Dr. Shephal Doshi
October 19, 2023
Conformal Medical to Present One-Year Data from its Left Atrial Appendage Occlusion (LAAO) Early Feasibility Study at TCT 2023
October 19, 2023 — Conformal Medical, Inc. announced today the one-year results from the company's CONFORMAL Early…
Read More
Edwards Lifesciences Corporation announced the company's EVOQUE tricuspid valve replacement system received CE Mark for the transcatheter treatment of eligible patients with tricuspid regurgitation
October 19, 2023
Edwards Evoque Transcatheter Tricuspid Valve Replacement System Receives CE Mark
October 19, 2023 — Edwards Lifesciences Corporation announced the company's EVOQUE tricuspid valve replacement system…
Read More
October 19, 2023
Results of SAFE-TAVI Clinical Study Anticipated at TCT 2023
October 19, 2023 — OpSens, a medical device cardiology-focused company, has announced that results of the “SAFE-TAVI…
Read More
Cardiovascular Research Foundation's (CRF) annual scientific symposium, Transcatheter Cardiovascular Therapeutics, TCT 2023, is set for October 23-26 in San Francisco
Christine Book
October 18, 2023
TCT 2023 Leadership Anticipates 'Practice Changing' Findings Ahead of 35th Scientific Symposium
October 18, 2023 — The following is an updated program preview of the Cardiovascular Research Foundation's (CRF) annual…
Read More
Study in low-risk patients reveals 5-year survival rate of 93%
October 18, 2023
Largest US Cardiac Database Shows Excellent Long-term Survival After Surgical Aortic Valve Replacement
October 18, 2023 — A study published in The Annals of Thoracic Surgery demonstrates outstanding long-term survival…
Read More
Study in low-risk patients reveals 5-year survival rate of 93%
October 18, 2023
Walgreens and the Cardiovascular Research Foundation Unite to Improve Recognition and Diagnosis of Valvular Heart Disease for Older Americans
October 18, 2023 — Walgreens and the Cardiovascular Research Foundation (CRF) announced a collaboration to drive…
Read More
Initial data indicate that DSR 2.0 is safe and well tolerated, restores diuretic response and improves cardiorenal status
October 18, 2023
Sequana Medical Announces Initial Positive Data from MOJAVE, a US Phase 1/2a Study of DSR 2.0 for Treatment of Heart Failure Through Breaking Vicious Cycle of Cardiorenal Syndrome
October 18, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and…
Read More
The Patel Children's Heart Institute at St. Joseph's Children's Hospital achieved a milestone recently, implanting its 250th congenital transcatheter heart valve.
October 17, 2023
St. Joseph's Children's Hospital Implants 250th Pulmonary Valve Without Open-Heart Surgery
October 17, 2023 — The Patel Children's Heart Institute at St. Joseph's Children's Hospital achieved a milestone…
Read More
University of Cincinnati to partner with UNC, Duke for large prospective study
October 17, 2023
Learning More About How Cancer Affects Stroke Risk
October 17, 2023 — Patients with a previous or current cancer diagnosis are more likely to have a stroke than the…
Read More
Scientists from The Florey are among the world’s leading stroke experts who have mapped out how researchers and clinicians can improve outcomes for people who have survived a stroke.
October 17, 2023
International Experts Push for Innovation to Improve Stroke Recovery
October 17, 2023 — Scientists from The Florey are among the world’s leading stroke experts who have mapped out how…
Read More
Hospitals see improvements but still struggling to reach pre-COVID treatment thresholds years after pandemic precautions upended longstanding processes
October 16, 2023
Challenges in Acute Heart Attack Care Continue Post COVID-19
October 16, 2023 — A door-to-balloon (D2B) time of 90-minutes or less is associated with improved outcomes for heart…
Read More
Building on the award-winning Allia platform for image guided therapies, GE HealthCare's new Allia IGS Pulse was designed to improve workflow for the diagnosis and treatment of cardiovascular diseases in interventional cardiology. (Photo: Business Wire) 
October 16, 2023
GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence
October 16, 2023 — GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest…
Read More
Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S. installation of a Trinias SCORE Opera C12 (ceiling mounted cutting edge angiography system) at Beaufort Memorial Hospital (Beaufort, SC).
October 16, 2023
Shimadzu Medical Systems USA Installs First Trinias Score Opera Cardiac Catheterization Lab in the US
October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S.…
Read More
SpotLight Duo is the second generation Arineta CT that it will sell and service directly
October 13, 2023
Arineta announces SpotLight Duo
October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now